Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2021

McCann R, Heidarian A, Pitman MB, Chebib I. Epithelioid hemangioendothelioma (EHE) involving pleural effusion. Diagn Cytopathol. 2021;49(2):328-330.

Yang HS, LaFrance DR, Hao Y. Elemental Testing Using Inductively Coupled Plasma Mass Spectrometry in Clinical Laboratories. Am J Clin Pathol. 2021;156(2):167-175.

Zouboulis CC, Shapiro LS, Magro CM. Atrophic papulosis: the wedge-shaped skin necrosis overlays an active lesion. J Eur Acad Dermatol Venereol. 2021;35(10):e672-e674.

Abuhelaiqa E, Snopkowski C, Li C, Salvatore S, Lee JR, Muthukumar T, et al. Validation of a noninvasive prognostic signature for allograft failure following BK virus associated nephropathy. Clin Transplant. 2021;35(2):e14200.

Haas T, Callum J, Grottke O, Asmis LM, Cushing MM. Response to Wirtz et al: The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients. Transfusion. 2021;61(3):991-992.

Haque M, Singh AK, Ouseph MM, Ahmed S. Regulation of Synovial Inflammation and Tissue Destruction by Guanylate Binding Protein 5 in Synovial Fibroblasts From Patients With Rheumatoid Arthritis and Rats With Adjuvant-Induced Arthritis. Arthritis Rheumatol. 2021;73(6):943-954.

Showalter K, Spiera R, Magro C, Agius P, Martyanov V, Franks JM, et al. Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement. Ann Rheum Dis. 2021;80(2):228-237.

Viswanathan K, Beg S, He B, Zhang T, Cantley R, Lubin DJ, et al. NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens. Am J Clin Pathol. 2021.

Miller DL, Ribeiro EA, Roy-Chowdhuri S, Illei PB, Siddiqui MT, Ali SZ. Renal medullary carcinoma involving serous cavity fluids: a cytomorphologic study of 12 cases. J Am Soc Cytopathol. 2021;10(2):187-196.

Bastos DC, Ribeiro CF, Ahearn T, Nascimento J, Pakula H, Clohessy J, et al. Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss. J Pathol. 2021;253(3):292-303.